PERRIGO Co plc Logo

PERRIGO Co plc

World's largest manufacturer of store-brand OTC consumer health products.

PRGO | US

Overview

Corporate Details

ISIN(s):
IE00BGH1M568
LEI:
Country:
United States of America
Address:
THE SHARP BUILDING, DUBLIN 2
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Perrigo Company plc is a leading global provider of consumer self-care products. The company develops, manufactures, and distributes a wide portfolio of over-the-counter (OTC) health and wellness solutions, including pain relievers, cough and cold remedies, allergy medications, digestive aids, and infant formula. A key focus of its business is serving as the world's largest manufacturer of OTC products for the store-brand or private-label market, supplying major retailers with affordable alternatives to national brands. With a history dating back to 1887, Perrigo is committed to empowering consumers with high-quality, effective products for self-managed health conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PERRIGO Co plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PERRIGO Co plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PERRIGO Co plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
Genfit S.A. Logo
Biopharma developing therapeutics and diagnostics for rare and life-threatening liver diseases.
United States of America GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea 225220
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830

Talk to a Data Expert

Have a question? We'll get back to you promptly.